MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, pulmonary arterial hypertension (PAH) and nontuberculous mycobacterial (NTM) lung disease. Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation. With a passionate team of Mannitarians collaborating nationwide, we are on a mission to give people control of their health and the freedom to live life. Please visit mannkindcorp.com to learn more.

Chiesi USA, Inc.

Chiesi USA, Inc., headquartered in Cary, N.C., is a specialty pharmaceutical company focused on commercialization of products for the hospital, rare disease and target office-based specialties. Our employees take an entrepreneurial approach to meet the evolving needs of our customers. As a Public Benefit Corporation, Chiesi USA is committed to operating as a good corporate citizen; positively impacting communities in which we live and serve. Headquartered in Cary NC, we employ over 360 employees in the United States. Previously known as Cornerstone Therapeutics, the company was acquired by the Chiesi Group in 2014. Chiesi USA, Inc. is a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A. Headquartered in Parma, Italy, Chiesi Farmaceutici is an international research-focused group with more than 80 years of experience in the pharmaceutical industry. The Group employs more than 5,300 people in 27 affiliates worldwide, selling products in more than 80 countries. Chiesi is recognized as a top 50 company in terms of revenue and R&D. Careers at Chiesi USA Inc: Email: Chiesiusa.jobs@chiesi.com Business Development: Email: us.busdev@chiesi.com All other inquiries: Email: us.contact@chiesi.com

neilmed pharmaceuticals

Ketan C. Mehta, MD and Nina Mehta, founded NeilMed® Pharmaceuticals, Inc. in January 2000 from Dr. Mehta's medical office and in a short span of 12 years, grew to 300 employees. NeilMed® is the largest manufacturer and supplier of LVLP (Large Volume Low Pressure) saline nasal irrigation systems in the world. The NeilMed brand of products help alleviate common nasal and sinus symptoms in a simple, safe, effective and affordable way. The company supplies millions of products to end users through various trade channels. NeilMed’s headquarters & manufacturing facility is based in Santa Rosa, California, USA. In addition worldwide offices and warehouses are located in Canada, Australia, New Zealand, UK, Malaysia, Singapore and India. At present active expansions are taking place in Southeast Asia and South America. NeilMed supplies to dozens of distributors in multiple countries. The unique business model has been a very strict vertical integration for achieving precision and fast execution at all levels. NeilMed prides itself in being a part of the small community of Santa Rosa, located in the heart of Sonoma County's wine country of Northern California. Flagship products are NeilMed SINUS RINSE™ and NeilMed NasaFlo® Neti Pot which are available in most stores in USA, Canada and several other countries. NeilMed currently has over 22 different products for nasal and sinus care and all the products are OTC (over the counter).

Paratek Pharmaceuticals

Positive outcomes. Positive patient stories. These are our priorities at Paratek Pharmaceuticals. As a commercial-stage biopharmaceutical company, we develop transformative solutions for patients with infectious diseases and other difficult to treat conditions, and we believe that we have the right people, the right knowledge and the right drug to make a difference in patients’ lives. Our Mission To create positive stories for patients, physicians and caregivers based on trust and integrity. To accomplish this, our employees work hard to turn everyday decisions into everyday triumphs that advance our technology and strengthen Paratek. Our Vision To be a leading independent biopharmaceutical company providing novel life-saving products for life-threatening diseases or other public health threats.

Amylyx Pharmaceuticals

We have an audacious mission to develop novel therapies for communities with high unmet needs. Where others see challenges, Amylyx sees opportunities that we pursue with urgency, rigorous science, and unwavering commitment. We explore scientific approaches that are tailored to diseases where we can make the greatest difference, agnostic of modality, in order to usher in a new era of advancements. See our community guidelines here: https://www.amylyx.com/social-media-guidelines Please be aware of potential phishing scams imitating Amylyx. All authentic communications from Amylyx will be from the Amylyx.com domain.